Naphthyridine compounds which inhibit tyrosine kinase and their pharmaceutical compositions
US5364860A · kind A · utility
5Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 1993 |
| Grant date | Nov 15, 1994 |
| Priority date | — |
| Expiry date | Jul 27, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the derivatives of the formula ##STR1## and their addition salts, and to their use in therapeutics, especially as drugs having antiproliferative properties and affording an effective treatment for diseases such as atherosclerosis, restenosis phenomena or any other pathological condition due to cell proliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.